COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,844 Articles (22,553 medRxiv, 8,291 bioRxiv)

Most recent first Previous |  Page 477: Articles 4761-4770  | Next

Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2
Attur, M. G., Petrilli, C. M., Adhikari, S., Iturrate, E., Li, X., Tuminello, S., Hu, N., Chakravarti, A., Beck, D. B., Abramson, S. B.
10.1101/2023.01.09.23284348 — Posted: 2023-01-11
A cross sectional survey examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic
Fuzzell, L., Brownstein, N. C., Fontenot, H. B., Lake, P., Michel, A., Whitmer, A., Rossi, S. L., McIntyre, M., Vadaparampil, S. T., Perkins, R. B.
10.1101/2023.01.11.23284437 — Posted: 2023-01-11
Country Learning on Maintaining Quality Essential Health Services (EHS) during COVID-19 in Timor-Leste: A mixed methods qualitative analysis
Kleine Bingham, M., Rangel, G., Sarakbi, D., Kelleher, T., Mensah Abrampah, N., Neilson, M., Bodson, O., White, P., Bothra, V., de Carvalho, H. M., da C.A. Pinto, F., Syed, S. B.
10.1101/2023.01.11.23284424 — Posted: 2023-01-11
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
Tartof, S. Y., Xie, F., Yadav, R., Wernli, K. J., Martin, E. T., Belongia, E. A., Gaglani, M., Zimmerman, R., Talbot, H. K., Thornburg, N., Flannery, B., US Flu VE Network Investigators, , Chung, J.
10.1101/2023.01.10.23284397 — Posted: 2023-01-11
Addressing spatial misalignment in population health research: a case study of US congressional district political metrics and county health data
Nethery, R. C., Testa, C., Tabb, L. P., Hanage, W. P., Chen, J. T., Krieger, N.
10.1101/2023.01.10.23284410 — Posted: 2023-01-11
Using early detection data to estimate the date of emergence of an epidemic outbreak
Jijon, S., Czuppon, P., Blanquart, F., Debarre, F.
10.1101/2023.01.09.23284284 — Posted: 2023-01-11
Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022.
Hoeve, C. E., de Gier, B., Huiberts, A. J., de Melker, H. E., Hahne, S. J. M., van den Hof, S., Knol, M. J.
10.1101/2023.01.10.23284386 — Posted: 2023-01-11
Bayesian sequential approach to monitor COVID-19 variants through positivity rate from wastewate
Montesinos Lopez, J. C., Daza-Torres, M. L., Garcia, Y. E., Herrera, C., Bess, C. W., Bischel, H. N., Nuno, M.
10.1101/2023.01.10.23284365 — Posted: 2023-01-11
Did COVID-19 or COVID-19 vaccines influence the patterns of Dengue in 2021: An exploratory analysis of two observational studies from North India
Kaur, U., Jethwani, P., Mishra, S., Dehade, A., Yadav, A. K., Chakrabarti, S., Chakrabarti, S. S.
10.1101/2023.01.09.23284366 — Posted: 2023-01-11
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
Shearer, F. M., McCaw, J. M., Ryan, G. E., Hao, T., Tierney, N., Lydeamore, M., Ellis, S., Ward, K., Wood, J., McVernon, J., Golding, N.
10.1101/2023.01.10.23284209 — Posted: 2023-01-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).